Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
15,857 | Dovepress* | 14,679+ | 1,609 | 16,288 | |
PubMed Central* | 1,178 | 320 | 1,498 | ||
Totals | 15,857 | 1,929 | 17,786 | ||
*Since 3 October 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar